126 related articles for article (PubMed ID: 3188007)
1. Protection against diisopropylfluorophosphate intoxication by meptazinol.
Galli A; Mazri A
Toxicol Appl Pharmacol; 1988 Sep; 95(3):388-96. PubMed ID: 3188007
[TBL] [Abstract][Full Text] [Related]
2. Prevention of physostigmine-induced lethality by the opioid analgesic meptazinol in the mouse.
Bottoncetti A; Galli A
Br J Pharmacol; 1987 Jun; 91(2):299-306. PubMed ID: 3607358
[TBL] [Abstract][Full Text] [Related]
3. Protection of acetylcholinesterase by meptazinol in mice exposed to di-isopropyl fluorophosphate. Comparison with physostigmine.
Galli A; Mori F
J Pharm Pharmacol; 1991 May; 43(5):366-9. PubMed ID: 1680183
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.
Galli A; Mori F
Arch Toxicol; 1991; 65(4):330-4. PubMed ID: 1953352
[TBL] [Abstract][Full Text] [Related]
5. In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine.
Galli A; Mori F; Gori I; Lucherini M
Biochem Pharmacol; 1992 Jun; 43(11):2427-33. PubMed ID: 1610407
[TBL] [Abstract][Full Text] [Related]
6. Prevention of diisopropylfluorophosphate (DFP)-induced lethality by meptazinol and 9-amino-tetrahydroacridine (THA) in the mouse.
Galli A; Mazri A; Mori F; Cecchini L; Lucherini M
Acta Physiol Hung; 1990; 75 Suppl():125-6. PubMed ID: 2371839
[No Abstract] [Full Text] [Related]
7. In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates.
Galli A; Malmberg Aiello P; Renzi G; Bartolini A
J Pharm Pharmacol; 1985 Jan; 37(1):42-8. PubMed ID: 2858526
[TBL] [Abstract][Full Text] [Related]
8. Acetylcholinesterase inhibition and protection by dizocilpine (MK-801) enantiomers.
Galli A; Mori F
J Pharm Pharmacol; 1996 Jan; 48(1):71-6. PubMed ID: 8722500
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in the development of tolerance to DFP toxicity.
Gupta RC; Patterson GT; Dettbarn WD
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S17-28. PubMed ID: 4092885
[TBL] [Abstract][Full Text] [Related]
10. Eptastigmine-phosphotriesterase combination in DFP intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
[TBL] [Abstract][Full Text] [Related]
11. Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine.
Harris L; Stitcher D
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):64-9. PubMed ID: 6493352
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase protection and the anti-diisopropylfluorophosphate efficacy of E2020.
Galli A; Mori F; Benini L; Cacciarelli N
Eur J Pharmacol; 1994 Apr; 270(2-3):189-93. PubMed ID: 8039548
[TBL] [Abstract][Full Text] [Related]
13. Genetically determined differences in acute responses to diisopropylfluorophosphate.
Smolen A; Smolen TN; Wehner JM; Collins AC
Pharmacol Biochem Behav; 1985 Apr; 22(4):623-30. PubMed ID: 3991771
[TBL] [Abstract][Full Text] [Related]
14. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicol Appl Pharmacol; 1996 Dec; 141(2):555-60. PubMed ID: 8975781
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice.
Tripathi HL; Dewey WL
J Toxicol Environ Health; 1989; 26(4):437-46. PubMed ID: 2709438
[TBL] [Abstract][Full Text] [Related]
16. Effects of PAM, proPAM, and DFP on behavior, thermoregulation, and brain AChE in rats.
Kenley RA; Howd RA; Uyeno ET
Pharmacol Biochem Behav; 1982 Nov; 17(5):1001-8. PubMed ID: 7178195
[TBL] [Abstract][Full Text] [Related]
17. Organophosphate-induced convulsions and prevention of neuropathological damages.
Tuovinen K
Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
[TBL] [Abstract][Full Text] [Related]
18. Interaction of cycloheximide and diisopropylphosphorofluoridate (DFP) during subchronic administration in rat.
Gupta RC; Dettbarn WD
Toxicol Appl Pharmacol; 1987 Aug; 90(1):52-9. PubMed ID: 3629591
[TBL] [Abstract][Full Text] [Related]
19. Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
Wu CS; Yang JT
Mol Pharmacol; 1989 Jan; 35(1):85-92. PubMed ID: 2913485
[TBL] [Abstract][Full Text] [Related]
20. Oxidative and histopathological alterations after sub-acute exposure of diisopropyl phosphorofluoridate in mice: Beneficial effect of N‑acetylcysteine.
John JJ; Nagar DP; Gujar NL; Bhattacharya R
Life Sci; 2019 Jul; 228():98-111. PubMed ID: 31051153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
